Table 5.
Postoperative outcomes.
| Outcome | Patient group | p-value | |
|---|---|---|---|
| Pre-ERP N = 50 |
ERP N = 50 |
||
| Total length of hospital stay (days), mean ± SD | 4.7 ± 2.3 | 3.0 ± 0.6 | <0.01 |
| Total length of hospital stay (days), median (range) | 4.0 (3, 17) | 3.0 (2, 5) | <0.01 |
| Use of PCA, N (%) | 50 (100%) | 3 (6.0%) | <0.01 |
| PCA duration (hours), mean ± SD | 46.8 ± 16.0 | 40.8 ± 21.8 | 0.10 |
| Oral morphine equivalent (mg), median (range) | |||
| Total | 276.3 (12.5, 1015.0) | 67.5 (0, 432.5) | <0.01 |
| POD 0 | 28.75 (0, 291.0) | 7.50 (0, 88.0) | <0.01 |
| POD 1 | 91.3 (5.0, 546.0) | 26.3 (0, 100.0) | <0.01 |
| POD 2 | 70.0 (0, 365.0) | 22.5 (0, 90.0) | <0.01 |
| POD 3 | 40.0 (0, 210.0) | 7.5 (0, 145.0) | <0.01 |
| POD 4 | 20.0 (0, 70.0) | 0 (0, 97.5) | <0.01 |
| POD 5 | 0 (0, 90.0) | 0 (0, 60.0) | <0.01 |
| Total acetaminophen use (mg), median (range) | |||
| Total | 5200.0 (0, 14000.0) | 8000.0 (0, 16000.0) | <0.01 |
| POD 0 | 325.0 (0, 3000.0) | 1000.0 (0, 2000.0) | <0.01 |
| POD 1 | 1000.0 (0, 3650,0) | 3000.0 (0, 5000.0) | <0.01 |
| POD 2 | 1300.0 (0, 3900.0) | 3000.0 (1000.0, 5000.0) | <0.01 |
| POD 3 | 1150.0 (0, 3000.0) | 1000.0 (0, 4000.0) | 0.25 |
| POD 4 | 975.0 (0, 3000.0) | 0 (0, 3000.0) | <0.01 |
| POD 5 | 0 (0, 3000.0) | 0 (0, 1000.0) | <0.01 |
| Ondansetron (mg), mean ± SD | |||
| Total | 5.92 ± 7.01 | 2.56 ± 5.28 | 0.01 |
| POD 0 | 1.92 ± 2.83 | 0.80 ± 1.81 | 0.02 |
| POD 1 | 1.36 ± 2.63 | 0.32 ± 1.36 | 0.02 |
| POD 2 | 1.12 ± 2.14 | 0.56 ± 1.81 | 0.16 |
| POD 3 | 0.88 ± 2.72 | 0.72 ± 2.38 | 0.76 |
| POD 4 | 0.40 ± 1.46 | 0.08 ± 0.57 | 0.15 |
| POD 5 | 0.24 ± 1.26 | 0.08 ± 0.57 | <0.01 |
(%): frequencies
ERP: enhanced recovery pathway. PCA: patient-controlled analgesia. POD: post-operative day. SD: standard deviation.